Study Assesses PET Agent for Detecting Pelvic Lymph Node Metastases in Patients with Prostate Cancer

For patients recently diagnosed with prostate cancer, the emerging positron emission tomography (PET) agent 18F-rhPSMA-7.3 reportedly has a 96 percent specificity rate for detecting pelvic lymph node metastases, according to Phase 3 study results recently presented at the 22nd Annual Scientific Meeting of the Society of Urologic Oncology (SUO).

Can AI Improve the Consistency of Breast Density Assessment by Radiologists?

In a recent video interview, Susan Holley, MD discussed key findings from a large retrospective longitudinal study, presented at the recent Radiological Society of North America (RSNA) conference, which found that an emerging artificial intelligence (AI) model was over 24 percent more consistent than radiologist assessment of breast density.

Clinical Histories in Radiology: Could They Get Worse?

Lamenting the deteriorating quality of clinical histories that radiologists receive from referring clinicians, this author comically speculates about clinical histories one may see in the near future.